August 05, 2026 | Press Release

Fewer Heart Attacks, More Cancer Cases, and Better Survival Chances

Lancet study: Researchers examine the effectiveness of disease prevention

Heart attacks, strokes, and hip fractures are becoming less common. Meanwhile, cancer cases are increasing, and more people are surviving these severe diseases. A new study by the Max Planck Institute for Demographic Research (MPIDR) and the Karolinska Institute examines how medical progress has impacted various diseases in Sweden.

Person looks at two large monitors displaying multiple MRI scans of brain and spine with medical data.

Medical advances over the past 100 years have changed patient profiles. © istockphoto.com / gorodenkoff

Medical progress is currently one of the strongest forces shaping populations and their health. For instance, an acute heart attack has evolved from being nearly always fatal in the past to having a much higher survival rate today. Researchers at the MPIDR and the Karolinska Institute in Stockholm, Sweden, have examined how disease prevention has affected various diseases in Sweden. The study was recently published in the journal The Lancet Regional Health – Europe.

The researchers analyzed Swedish registry data to identify new cases of heart attacks, strokes, hip fractures, and malignant cancers. For individuals aged 60 to 90, the researchers calculated age-specific incidence rates, as well as the proportion of survivors one and five years after diagnosis. They also determined the prevalence — that is, the proportion of people with the disease — at the ages of 70, 80, and 90. The calculations were based on the birth cohorts from 1904 to 1960 that were observed from 1987 to 2022.

Infographic with four line charts for heart attack, stroke, hip fracture, and cancer showing increasing or decreasing incidence rates by age group.

Age-specific incidence rates (logarithmic scale) of heart attack, stroke, hip fracture, and cancer at diagnosis ages 60–90 for men and women, birth cohorts 1910, 1920, 1930, 1940, and 1950, Sweden. © MPIDR

download figure (PNG File, 475 kB)

Advances in prevention and improved treatment following diagnosis

"The patterns of change in incidence and survival are disease-specific. For heart attacks, strokes, and hip fractures, the declines in incidence have outpaced improvements in survival. This means that advances in preventing severe acute events are so significant that they result in a decreasing prevalence of these diseases in the population," explains Anna-Kathleen Piereth, a researcher and PhD student at the MPIDR and the Karolinska Institute. For example, the incidence rate of heart attacks among 75-year-old women has halved over a 20-year period, from those born in 1920 to the 1940 cohort. At the same time, the proportion of survivors one year after diagnosis increased by nearly 50 percent—from 51 percent in the 1920 cohort to 75 percent in the 1940 cohort.

Infographic with four line charts showing one-year survival rates for heart attack, stroke, hip fracture, and cancer by age and birth cohort

One-year survival proportion of heart attack, stroke, hip fracture, and cancer at diagnosis ages 60–90 for men and women, birth cohorts 1910, 1920, 1930, 1940, and 1950, Sweden. © MPIDR

download figure (PNG File, 449 kB)

However, the situation is different for malignant cancers. Here, the number of new cases is rising. At the same time, survival proportions have improved significantly in recent decades as cancer diagnosis and treatment have become more effective. As a result, the prevalence of the disease in the population has increased substantially. While 17.3% of men in the 1912 birth cohort were diagnosed with cancer between the ages of 80 and 89, this figure increased to 20.7% in the 1931 birth cohort—a rise of about one-fifth.

Infographic with four line charts on heart attack, stroke, hip fracture, and cancer, each showing age groups and birth cohorts, with explanatory text at the bottom.

Prevalence (%) of heart attack, stroke, hip fracture and cancer in men and women aged 70, 80, and 90, birth cohorts 1912–1952, Sweden. (Age-specific prevalence proportions were based on incident cases occurring within the 60–69, 70–79, and 80–89 age ranges and surviving until the beginning of age 70, 80, and 90, divided by the population alive at the beginning of age 70, 80, and 90, respectively.) © MPIDR

download figure (PNG File, 405 kB)

"Our results suggest that medical progress has been greatest in the prevention of heart attacks, strokes, and hip fractures, while for cancer, it has been especially effective in diagnosis and subsequent treatment," said Piereth.

The disease burden of the Swedish population, which represents a low-mortality population, has shifted. Severe acute events have been prevented more often, while cancer cases have risen and can be treated more effectively.

Although there are differences between countries in the implementation of preventive innovations, the distribution of risk factors, and the health care systems themselves, the findings for Sweden may be generalized. "Because high-income countries share similar medical knowledge, we assume that our findings can serve as a benchmark for understanding trends observed in other populations with low mortality, even if they are at a different stage of development than Sweden."

New disease histories are changing care needs

"The results show, for the first time, which force—disease prevention or disease management—has had a stronger impact on disease prevalence and how their combined effect, which we refer to as the incidence-survival gap, has altered population health and the population composition," explains Piereth.

The researchers emphasize that the shift in the disease burden is changing individual disease histories. "Integrated care approaches are becoming increasingly important to effectively address complex disease histories from an interdisciplinary, cross-sectoral, and patient-centered perspective," says Piereth.

Original Publication

Piereth, A.-K.; Schmidt-Mende, K.; Modig, K.; Ebeling, M.:
The Lancet Regional Health - Europe 68:101785, 1–13. (2026)       

Contact

Anna-Kathleen Piereth, Research Scientist and PhD student at MPIDR and Karolinska Institute
piereth@demogr.mpg.de

Marcus Ebeling, Head of the research group "Medical Demography"
ebeling@demogr.mpg.de

Silvia Leek, Head of PR Department at MPIDR
presse@demogr.mpg.de
+49 (0)381 20 81 143

Keywords

Disease prevention | Incidence | Survival | Prevalence | Major diseases | Cohort-to-cohort change

Contact

Head of Public Relations and Communications

Silvia Leek

E-Mail

+49 381 2081-143

Science Communication Editor

Silke Schulz

E-Mail

+49 381 2081-153

What next?

To the Home Page

Max-Planck-Gesellschaft - Logo
The Max Planck Institute for Demographic Research (MPIDR) in Rostock is one of the leading demographic research centers in the world. It's part of the Max Planck Society, the internationally renowned German research society.